Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1221685rdf:typepubmed:Citationlld:pubmed
pubmed-article:1221685lifeskim:mentionsumls-concept:C0175677lld:lifeskim
pubmed-article:1221685lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:1221685lifeskim:mentionsumls-concept:C0205147lld:lifeskim
pubmed-article:1221685lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:1221685pubmed:issue11lld:pubmed
pubmed-article:1221685pubmed:dateCreated1976-6-2lld:pubmed
pubmed-article:1221685pubmed:abstractTextThe use of antitetanus serum (ATS) in the north taiga soil-vegetative zone and farther to the north is inexpedient because of an insignificant contamination of soil with B. tetani and a trivial contact of the population with soil. In the Arkhangelsk region with a high incidence of trauma and a low tetanus morbidity the damage caused to the population by the administration of ATS in the form of serum sickness (1.1% of the persons given ATS injections) and anaphylactic shock considerably exceeded the value of negative results of the infection. In the presence of immune population (over 86% of the children and 82% of adults are immune) and with additional vaccination of definite groups it is not only possible, but necessary to suspend ATS injections in trauma; instead, 0.5 ml of tetanus toxoid should be used for revaccination. Suspension of ATS application in trauma gives marked economy of the budget of the public health of the region.lld:pubmed
pubmed-article:1221685pubmed:languageruslld:pubmed
pubmed-article:1221685pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1221685pubmed:citationSubsetIMlld:pubmed
pubmed-article:1221685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1221685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1221685pubmed:statusMEDLINElld:pubmed
pubmed-article:1221685pubmed:monthNovlld:pubmed
pubmed-article:1221685pubmed:issn0372-9311lld:pubmed
pubmed-article:1221685pubmed:authorpubmed-author:SergeevaT ITIlld:pubmed
pubmed-article:1221685pubmed:authorpubmed-author:IastrebovV...lld:pubmed
pubmed-article:1221685pubmed:issnTypePrintlld:pubmed
pubmed-article:1221685pubmed:ownerNLMlld:pubmed
pubmed-article:1221685pubmed:authorsCompleteYlld:pubmed
pubmed-article:1221685pubmed:pagination106-9lld:pubmed
pubmed-article:1221685pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1221685pubmed:meshHeadingpubmed-meshheading:1221685-...lld:pubmed
pubmed-article:1221685pubmed:meshHeadingpubmed-meshheading:1221685-...lld:pubmed
pubmed-article:1221685pubmed:meshHeadingpubmed-meshheading:1221685-...lld:pubmed
pubmed-article:1221685pubmed:meshHeadingpubmed-meshheading:1221685-...lld:pubmed
pubmed-article:1221685pubmed:meshHeadingpubmed-meshheading:1221685-...lld:pubmed
pubmed-article:1221685pubmed:meshHeadingpubmed-meshheading:1221685-...lld:pubmed
pubmed-article:1221685pubmed:year1975lld:pubmed
pubmed-article:1221685pubmed:articleTitle[The expediency and feasibility of abolishing the use of antitetanus serum for injuries in the Arkhangel'sk region].lld:pubmed
pubmed-article:1221685pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1221685pubmed:publicationTypeEnglish Abstractlld:pubmed